On Friday, Teladoc Health Inc (NYSE: TDOC) was 2.94% up from the session before settling in for the closing price of $8.17. A 52-week range for TDOC has been $6.76 – $15.68.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 41.76% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 83.83%. With a float of $171.93 million, this company’s outstanding shares have now reached $173.41 million.
In an organization with 5500 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 63.2%, operating margin of -8.52%, and the pretax margin is -38.67%.
Teladoc Health Inc (TDOC) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Teladoc Health Inc stocks. The insider ownership of Teladoc Health Inc is 1.00%, while institutional ownership is 73.78%. The most recent insider transaction that took place on Mar 20 ’25, was worth 173,416. In this transaction CHIEF FINANCIAL OFFICER of this company sold 20,586 shares at a rate of $8.42, taking the stock ownership to the 116,309 shares. Before that another transaction happened on Mar 20 ’25, when Company’s CHIEF LEGAL OFFICER, SECRETARY sold 11,011 for $8.42, making the entire transaction worth $92,757. This insider now owns 64,308 shares in total.
Teladoc Health Inc (TDOC) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 83.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 48.98% during the next five years compared to -33.66% drop over the previous five years of trading.
Teladoc Health Inc (NYSE: TDOC) Trading Performance Indicators
You can see what Teladoc Health Inc (TDOC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.57. Likewise, its price to free cash flow for the trailing twelve months is 5.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.88, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -0.86 in one year’s time.
Technical Analysis of Teladoc Health Inc (TDOC)
Let’s dig in a bit further. During the last 5-days, its volume was 5.86 million. That was inferior than the volume of 8.0 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 18.12%. Additionally, its Average True Range was 0.67.
During the past 100 days, Teladoc Health Inc’s (TDOC) raw stochastic average was set at 6.46%, which indicates a significant decrease from 23.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.54% in the past 14 days, which was lower than the 70.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.35, while its 200-day Moving Average is $9.44. However, in the short run, Teladoc Health Inc’s stock first resistance to watch stands at $8.63. Second resistance stands at $8.86. The third major resistance level sits at $9.20. If the price goes on to break the first support level at $8.06, it is likely to go to the next support level at $7.72. The third support level lies at $7.49 if the price breaches the second support level.
Teladoc Health Inc (NYSE: TDOC) Key Stats
There are 173,672K outstanding shares of the company, which has a market capitalization of 1.46 billion. As of now, sales total 2,570 M while income totals -1,001 M. Its latest quarter income was 640,490 K while its last quarter net income were -48,410 K.
